AFT to pay first dividend as income soars 20%

Kiwi Maxigesic owner posts $NZD20m profit boosted by licensing income  AFT Pharmaceuticals, the New Zealand-headquartered outfit best known for its Maxigesic ibuprofen/paracetamol combination, will pay its first dividend in its eight year history as a publicly listed company on the back of boosted revenue. The dual NZX/ASX-listed company’s full year FY2023 result showed its operating